Literature DB >> 25860357

[Coverage of the gallbladder cancer prevention strategy in Chile: results from the 2009-2010 National Health Survey].

Gonzalo Latorre S, Danisa Ivanovic-Zuvic S, Óscar Corsi S, Gonzalo Valdivia C, Paula Margozzini M, Ricardo Olea O, José Chianale B, Juan Francisco Miquel P.   

Abstract

BACKGROUND: In Chile, gallbladder cancer (GBC) is one of the most important causes of death and gallstone disease (GSD) is its main risk factor. Abdominal ultrasonography (AU) is used for the diagnosis of GSD and cholecystectomy is used to prevent it. AIM: To estimate GSD prevalence in the general population and to assess the diagnostic and therapeutic coverage of GSD as a preventive strategy for GBC in Chile.
MATERIAL AND METHODS: A standardized digestive symptoms questionnaire of the 2009-2010 Chilean National Health Survey was answered by 5412 adults over 15 years old. Self-reports of AU, GBD and cholecystectomies were recorded.
RESULTS: The prevalence of biliary-type pain was 7.1%. During the last five years, the prevalence of AU was 16%. GSD was reported in 20% of these tests and 84% of them were asymptomatic. The prevalence of AU was significantly lower in Araucanía region and among people with less than 12 years of education. Life cholecystectomy prevalence was 11% and reached 40% in people aged over 60 years. Women accounted for 75% of total cholecystectomies. Twenty-one percent of individuals who referred biliary-type pain, were studied with an AU. Only 60% of people with GSD confirmed by AU underwent a cholecystectomy.
CONCLUSIONS: GSD affects at least 27% of the Chilean adult population. Important deficits and inequities in GSD diagnostic and therapeutic coverage were identified.

Entities:  

Mesh:

Year:  2015        PMID: 25860357     DOI: 10.4067/S0034-98872015000200002

Source DB:  PubMed          Journal:  Rev Med Chil        ISSN: 0034-9887            Impact factor:   0.553


  3 in total

1.  Gallbladder and extrahepatic bile duct cancers in the Americas: Incidence and mortality patterns and trends.

Authors:  Adalberto Miranda-Filho; Marion Piñeros; Catterina Ferreccio; Volkan Adsay; Isabelle Soerjomataram; Freddie Bray; Jill Koshiol
Journal:  Int J Cancer       Date:  2020-01-21       Impact factor: 7.316

Review 2.  Cancer of the gallbladder-Chilean statistics.

Authors:  Luis Villanueva
Journal:  Ecancermedicalscience       Date:  2016-12-21

Review 3.  Evolving Paradigms in the Systemic Treatment of Advanced Gallbladder Cancer: Updates in Year 2022.

Authors:  Zishuo Ian Hu; Kian-Huat Lim
Journal:  Cancers (Basel)       Date:  2022-02-28       Impact factor: 6.639

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.